DD118992A2 - - Google Patents

Info

Publication number
DD118992A2
DD118992A2 DD18537175A DD18537175A DD118992A2 DD 118992 A2 DD118992 A2 DD 118992A2 DD 18537175 A DD18537175 A DD 18537175A DD 18537175 A DD18537175 A DD 18537175A DD 118992 A2 DD118992 A2 DD 118992A2
Authority
DD
German Democratic Republic
Application number
DD18537175A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to DD18537175A priority Critical patent/DD118992A2/xx
Publication of DD118992A2 publication Critical patent/DD118992A2/xx

Links

DD18537175A 1975-04-11 1975-04-11 DD118992A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DD18537175A DD118992A2 (fr) 1975-04-11 1975-04-11

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DD18537175A DD118992A2 (fr) 1975-04-11 1975-04-11

Publications (1)

Publication Number Publication Date
DD118992A2 true DD118992A2 (fr) 1976-04-05

Family

ID=5499891

Family Applications (1)

Application Number Title Priority Date Filing Date
DD18537175A DD118992A2 (fr) 1975-04-11 1975-04-11

Country Status (1)

Country Link
DD (1) DD118992A2 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135109A1 (fr) * 1983-08-19 1985-03-27 Nissan Chemical Industries Ltd. Agent antiathérosclérotique
US4639444A (en) * 1984-11-30 1987-01-27 Nissan Chemical Industries Ltd. 3,5-dialkyl-4,6-diaryl-tetrahydro-2H-13,5-thiadiazine-2-thione derivative, process for its production and antihyperlipidemic agent containing it

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135109A1 (fr) * 1983-08-19 1985-03-27 Nissan Chemical Industries Ltd. Agent antiathérosclérotique
US4624950A (en) * 1983-08-19 1986-11-25 Nissan Chemical Industries Ltd. Method for treating atherosclerosis hyperlipidema, lipid deposition on arterial walls, or raising the ratio of high density lipoprotein cholesterol to total cholesterol in serum
US4639444A (en) * 1984-11-30 1987-01-27 Nissan Chemical Industries Ltd. 3,5-dialkyl-4,6-diaryl-tetrahydro-2H-13,5-thiadiazine-2-thione derivative, process for its production and antihyperlipidemic agent containing it

Similar Documents

Publication Publication Date Title
JPS5735480B2 (fr)
FR2317792B1 (fr)
JPS5334987B2 (fr)
JPS5284191U (fr)
JPS5725170Y2 (fr)
JPS5266202U (fr)
JPS5198942U (fr)
JPS51135872U (fr)
CH598420A5 (fr)
CH597614A5 (fr)
CH603240A5 (fr)
BG21073A1 (fr)
CH602464A5 (fr)
CH601947A5 (fr)
CH601912A5 (fr)
CH601240A5 (fr)
CH601099A5 (fr)
CH600290A5 (fr)
CH600215A5 (fr)
CH599791A5 (fr)
BG22301A1 (fr)
CH599590B5 (fr)
CH599589B5 (fr)
CH599544A5 (fr)
CH599109A5 (fr)